Founded in 2013, SOLS uses state of the art computer vision and machine learning to improve the fit and function of footwear. We are backed by blue-chip investors like Founders Fund, Lux Capital and Tenaya Capital and located in New York City.
To date, the company has launched two products: SOLSRx, medical grade 3D printed orthotics and ExoSOLS, direct to consumer custom insoles. SOLS is now leveraging its patented footwear customization software to attack the footwear industry's biggest problem, shoe size related returns.
Our products sit at the intersection of technology and the human body. We are trailblazing the path towards mass customization.